Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies. To accomplish this mission, we are dedicated to achieving these goals in Washington, D.C. and across the country.

Featured Blogs

What’s really happening when it comes to prescription drug costs

Katie Koziara
New data show how robust competition continues to keep national spending on life-saving medicines in check, even as new innovative treatments reach patients.

Analysis: States can help patients save nearly $1,000 annually on their medicines

Reid Porter
States can enact legislation today requiring insurers and PBMs to share the rebates they negotiate from manufacturers with individual patients.

New analysis confirms hospitals markup prices for oncology therapies

Gabby Migliara
Hospitals may earn greater revenue per unit from cancer therapies than the pharmaceutical companies that manufactured them.